POMC and Cowden disease: In this context, De Bruin and collaborators examined the expression of dopamine (DA) and somatostatin (SS) receptors [52], as compounds targeting these receptors are currently used to successfully reduce ACTH and cortisol levels in subsets of human CD patients.